CBD maker Elixinol launches joint venture with RFI Ingredients

The new joint venture operates as Infusion Strategies and brings raw material and formulation expertise that will allow RFI create new CBD-related products

picture of

Breaking News

CBD maker Elixinol launches joint venture with RFI Ingredients

The new joint venture operates as Infusion Strategies and brings raw material and formulation expertise that will allow ...

Lonza expands HPAPI production capacity in Visp

This expansion in Switzerland will add two 4 m3-scale, multi-purpose production lines for HPAPI manufacturing

ERS Genomics licences CRISPR technology to Bioneer

The non-exclusive licence is to further advance preclinical disease modelling

Cannabis Europa 2019 puts CBD in the spotlight

Industry leaders will gather in London to discuss what lies ahead for the medical cannabis industry in Europe

Particle Sciences expands controlled substance capabilities

The Drug Enforcement Administration has granted authorisation to the CDMO for Schedule I substances

FDA approves Novartis gene therapy with a $2m price tag

Gene therapy seems to be the miracle drug for spinal muscular atrophy, with the one-time dose nature of the drug the ...

Establishing a secure supply chain for phyto-APIs

APIs produced from naturally derived materials can be challenging to supply reliably and with consistently high quality. ...

FDA allows ADMA intravenous globulin back on the market

This is not the first release of this drug to the US, after initial approval in 2012, it was removed due to ...

Rousselot to highlight new cell viability study on X-Pure at BIO 2019

The gelatin and collagen peptide producer will exhibit at booth 326 at BIO 2019, the trade show in Philadelphia held ...

Five key takeaways from LogiChem EU 2019

Having recently attended the LogiChem EU 2019 event in Amsterdam, the Netherlands, LLamasoft's Dr Madhav Durbha shares ...

A natural remedy for brain metastasis

Milk thistle extract might be a promising complementary treatment for cancer patients, reports Andrea Zangara, ...

Small molecule CDMOs reacting to changing market demands

The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...

Helsinn brings cancer pain management option to China

With the help of Mundipharma China Pharmaceutical, ALOXI IV will be used for the prevention of chemotherapy-induced ...

Vedanta upholds patent of clostridial bacterial compositions

The Honda patent was opposed by six parties including Seres Therapeutics and Nestec, a Nestlé subsidiary